We are one of the three largest University Hospitals in Germany and with more than 14,500 employees, the largest employer in the state of Schleswig-Holstein. We perform university medical research and teaching at 51 clinics and 26 institutes at our medical faculties in Kiel and Lübeck.
The Institute of Clinical Molecular Biology is focused on the understanding of the pathophysiology of chronic inflammatory disease, namely inflammatory bowel disease and has contributed in the recent to the molecular understanding how IBD risk genes transform into chronic intestinal inflammation in human. The Institute is one of the core research centres in various national and international research alliances (e.g. DFG ExC, BMBF consortia iTREAT, GUIDE-IBD and Try-IBD, H2020 SYSCID, IMI2 3TR and ImmUniverse).
We are looking for professional and competent support as early as possible. One PostDoc position (2 years) is available at the Institute of Clinical Molecular Biology.
Our lab focuses on the role of host-microbial interaction and instruction of intestinal immunity in the context of intestinal inflammation. We are investigating how IBD risk genes (e.g. ATG16L1, XBP1) promote epithelial cell dysfunction in the context of intestinal inflammation (Nature 2013, Journal of Experimental Medicine 2018, Science 2019) and intestinal carcinogenesis (Nature 2016, Gastroenterology 2018). We employ omics-based approaches to identify novel immunometabolic principles in the pathogenesis of IBD (Gut 2019, Gastroenterology 2019).
The advertised position will work within the DFG-funded Excellence Cluster “Precision Medicine in Chronic Inflammation”. Within the anticipated project we aim to broaden our understanding of the biochemical interplay between diet, the human intestinal microbiome, and immunometabolic pathways in chronic inflammatory diseases such as inflammatory bowel disease, rheumatic arthritis, or psoriasis. In this context we aim to investigate the role of amino-acid immunometabolism and understand its impact on host-microbial co-metabolism in the context of intestinal inflammation. Using metabolic modelling approaches we strive to identify novel diagnostic or therapeutic entry points for precision medicine in IBD.
Your skills and qualifications:
Tagged as: Computer Science, Life Sciences
The Transregio TRR 305 is a DFG-funded collaborative research consortium between the Universities of Regensburg, Erlangen, and the Fraunhofer Society...Apply
About this position The European Molecular Biology Laboratory (EMBL) is seeking a bright postdoctoral candidate to investigate the control of...Apply
A position as System Admin / Cloud Specialist for the recently launched infrastructure initiative German Human Genome-Phenome Archive (GHGA, www.ghga.de)...Apply
The Antebi Department for “Molecular Genetics of Ageing” investigates how regulatory networks govern animal health and life span. We primarily...Apply
About this position We are looking for a computational genomics expert to join a team of EMBL and GSK scientists...Apply
Postdoctoral Fellow (m/f/x) in Immunology Institute of Clinical Microbiology, Immunology and Hygiene, Universitätsklinikum Erlangen, and Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Germany; research...Apply